Helicobacter pylori. Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters
Conditions
Interventions
Intervention group takethe 14 days treatment of bismuthe subcirate 240 mg twice a day made by Kimidarou, pantoprazole 20 mg twice a day made by Takeda, amoxicilline 1 gr twice a day made by Kosar, cl
first 7 days of bismuthe subcirate 240 mg twice a day made by Kimidarou, pantoprazole 20 mg twice a day made by Takeda, amoxicilline 1 gr twice a day made by Kosar, meteronidazole 500 mg twice a day m
Treatment - Drugs
Sponsors
Guilan Univercity of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: • Inclusion criteria: Positive helicobacter pylori in the endoscopy and no therapeutic regimen for treatment • Exclusion criteria: Pregnant and breast feeding women, gastric and esophageal malignancy, cirrhosis, heart and kidney failure, history of seizure, hematologic diseases, and allergy to medications, patients with incomplete treatment period, severe side effects, and no satisfaction to continue treatment
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Helicobacter pylori eradication. Timepoint: 12 weeks. Method of measurement: Ureas Breath Test with C14. | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of helicobacter pylori eradication of fourteen days regimen of four medications “bismuthe subcirate, pantoprazole, amoxicilline, clarithromycin” with seven days sequential regimen of “bismuthe subcirate, pantoprazole, amoxicilline, meteronidazole” and “bismuthe subcirate, pantoprazole, amoxicilline, furazolidone”. Timepoint: 2-4 weeks. Method of measurement: 2-4 weeks. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Farahnaz Joukar
Gastrointestinal and Liver Diseases Research Center
Outcome results
None listed